Cardlytics Statistics
Total Valuation
Cardlytics has a market cap or net worth of $24.51 million. The enterprise value is $174.73 million.
| Market Cap | 24.51M |
| Enterprise Value | 174.73M |
Important Dates
The next estimated earnings date is Wednesday, August 5, 2026, after market close.
| Earnings Date | Aug 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Cardlytics has 5.81 million shares outstanding. The number of shares has increased by 6.65% in one year.
| Current Share Class | 5.81M |
| Shares Outstanding | 5.81M |
| Shares Change (YoY) | +6.65% |
| Shares Change (QoQ) | +1.06% |
| Owned by Insiders (%) | 4.53% |
| Owned by Institutions (%) | 20.78% |
| Float | 5.02M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.12 |
| Forward PS | 0.16 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 2.46 |
| P/OCF Ratio | 2.37 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.83 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 17.53 |
Financial Position
The company has a current ratio of 2.17
| Current Ratio | 2.17 |
| Quick Ratio | 2.12 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | 21.08 |
| Interest Coverage | -3.53 |
Financial Efficiency
Return on equity (ROE) is -356.04% and return on invested capital (ROIC) is -9.93%.
| Return on Equity (ROE) | -356.04% |
| Return on Assets (ROA) | -7.70% |
| Return on Invested Capital (ROIC) | -9.93% |
| Return on Capital Employed (ROCE) | -19.07% |
| Weighted Average Cost of Capital (WACC) | 4.53% |
| Revenue Per Employee | $942,665 |
| Profits Per Employee | -$422,705 |
| Employee Count | 224 |
| Asset Turnover | 0.67 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -76.29% in the last 52 weeks. The beta is 0.62, so Cardlytics's price volatility has been lower than the market average.
| Beta (5Y) | 0.62 |
| 52-Week Price Change | -76.29% |
| 50-Day Moving Average | 5.89 |
| 200-Day Moving Average | 10.94 |
| Relative Strength Index (RSI) | 33.77 |
| Average Volume (20 Days) | 64,678 |
Short Selling Information
The latest short interest is 686,347, so 11.82% of the outstanding shares have been sold short.
| Short Interest | 686,347 |
| Short Previous Month | 728,104 |
| Short % of Shares Out | 11.82% |
| Short % of Float | 13.66% |
| Short Ratio (days to cover) | 7.36 |
Income Statement
In the last 12 months, Cardlytics had revenue of $211.16 million and -$94.69 million in losses. Loss per share was -$17.58.
| Revenue | 211.16M |
| Gross Profit | 100.21M |
| Operating Income | -39.01M |
| Pretax Income | -106.97M |
| Net Income | -94.69M |
| EBITDA | -15.64M |
| EBIT | -39.01M |
| Loss Per Share | -$17.58 |
Balance Sheet
The company has $59.80 million in cash and $210.03 million in debt, with a net cash position of -$150.23 million or -$25.87 per share.
| Cash & Cash Equivalents | 59.80M |
| Total Debt | 210.03M |
| Net Cash | -150.23M |
| Net Cash Per Share | -$25.87 |
| Equity (Book Value) | -4.00M |
| Book Value Per Share | -0.73 |
| Working Capital | 69.17M |
Cash Flow
In the last 12 months, operating cash flow was $10.35 million and capital expenditures -$389,000, giving a free cash flow of $9.97 million.
| Operating Cash Flow | 10.35M |
| Capital Expenditures | -389,000 |
| Depreciation & Amortization | 23.37M |
| Net Borrowing | -11.00M |
| Free Cash Flow | 9.97M |
| FCF Per Share | $1.72 |
Margins
Gross margin is 47.46%, with operating and profit margins of -18.47% and -44.84%.
| Gross Margin | 47.46% |
| Operating Margin | -18.47% |
| Pretax Margin | -50.66% |
| Profit Margin | -44.84% |
| EBITDA Margin | -7.41% |
| EBIT Margin | -18.47% |
| FCF Margin | 4.72% |
Dividends & Yields
Cardlytics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.65% |
| Shareholder Yield | -6.65% |
| Earnings Yield | -386.33% |
| FCF Yield | 40.66% |
Analyst Forecast
The average price target for Cardlytics is $10.75, which is 154.74% higher than the current price. The consensus rating is "Hold".
| Price Target | $10.75 |
| Price Target Difference | 154.74% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 87.08% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 8, 2026. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jun 8, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
Cardlytics has an Altman Z-Score of -6.67 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.67 |
| Piotroski F-Score | 5 |